Drug combination therapies. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Cell Line Kidney

Organisms8

Plasmodium falciparum Mice, Nude Mice, SCID Mice, Inbred BALB C HIV-1 Hepacivirus Mice, Inbred C57BL Rats, Sprague-Dawley

Diseases23

Malaria, Falciparum Malaria Hepatitis C, Chronic Neoplasms Parasitemia Disease Models, Animal Drug-Related Side Effects and Adverse Reactions HIV Infections Multiple Myeloma Lung Neoplasms Breast Neoplasms Recurrence Hypertension Ovarian Neoplasms Leukemia L1210 Pancreatic Neoplasms Glioblastoma Brain Neoplasms Hepatitis B, Chronic Disease Progression Adenocarcinoma Leukemia, Myeloid, Acute Arthritis, Rheumatoid

Chemicals and Drugs147

Drug Combinations Artemisinins Antimalarials Fluorenes Antineoplastic Agents Amodiaquine Mefloquine Pyrimethamine Antiviral Agents Sulfadoxine Proguanil Ribavirin Ethanolamines Sesquiterpenes Methenamine Chloroquine Dapsone Pyrazines Interferon-alpha Antihypertensive Agents Deoxycytidine Atovaquone Cisplatin Boronic Acids Fluorouracil Antifungal Agents Anti-Bacterial Agents Quinolines Methylthioinosine Cyclopentolate Rifampin Anti-HIV Agents Doxorubicin Methotrexate Pyrimidines Tropicamide Amphotericin B Cellophane Paclitaxel Floxuridine Niacinamide Piperazines Echinocandins Phenylurea Compounds Sulfamethoxazole Antimetabolites, Antineoplastic Benzenesulfonates Taxoids Amikacin Reverse Transcriptase Inhibitors Naphthoquinones Triazoles Pharmaceutical Preparations Adenine Polyethylene Glycols Quinazolines Sirolimus Antiprotozoal Agents Antibodies, Monoclonal Nanoconjugates Cyclophosphamide Angiotensin-Converting Enzyme Inhibitors Sulfonamides Pyridines Hydroxamic Acids Antibodies, Monoclonal, Humanized Benzimidazoles Sulfasalazine Zidovudine Vincristine Phentermine Pyrroles Lamivudine Protein Kinase Inhibitors Antitubercular Agents Organophosphonates Piperidines Cytarabine Indoles Antineoplastic Agents, Phytogenic Benzamides Dacarbazine Camptothecin Hydrochlorothiazide Amlodipine Immunosuppressive Agents Thiazoles Antineoplastic Agents, Alkylating Ethambutol Itraconazole Histone Deacetylase Inhibitors Trimethoprim Enzyme Inhibitors Triazines Tacrolimus Guanine Etoposide Fluconazole Tetrazoles Antirheumatic Agents Carboplatin Medetomidine Recombinant Proteins Oxonic Acid Nitroimidazoles Imidazoles Benzoquinones Angiotensin II Type 1 Receptor Blockers Pyrazinamide Aspirin Adrenergic beta-Antagonists Didanosine Azetidines Nifurtimox Angiogenesis Inhibitors Vinblastine Dexamethasone TOR Serine-Threonine Kinases Proto-Oncogene Proteins c-bcl-2 Receptor, Epidermal Growth Factor Fenofibrate Ketamine Hydroxychloroquine Tegafur Bronchodilator Agents Analgesics Adrenal Cortex Hormones Hypoglycemic Agents Albuterol Metformin Prednisolone Diuretics Simvastatin Anti-Asthmatic Agents Receptor, erbB-2 Hypolipidemic Agents Immunologic Factors Hydroxymethylglutaryl-CoA Reductase Inhibitors Glucocorticoids Lisinopril Proto-Oncogene Proteins c-akt Aminoglycosides RNA, Viral Thalidomide Adrenergic beta-2 Receptor Agonists Niacin Anticholesteremic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment45

Drug Therapy, Combination Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Xenograft Model Antitumor Assays Drug Administration Schedule Drug Therapy Drug Screening Assays, Antitumor Combined Modality Therapy Drug Evaluation, Preclinical Inhibitory Concentration 50 Microbial Sensitivity Tests Clinical Trials as Topic Molecular Targeted Therapy Parasitic Sensitivity Tests Administration, Oral Disease Models, Animal Nanoconjugates Drug Design Treatment Failure Models, Biological Drug Discovery Drug Evaluation Clinical Trials, Phase I as Topic Neoplasm Transplantation Survival Analysis Double-Blind Method Drug Delivery Systems Area Under Curve Infusions, Intravenous Models, Statistical Random Allocation Blood Pressure Disease-Free Survival Randomized Controlled Trials as Topic Retrospective Studies Flow Cytometry Survival Rate Blotting, Western Models, Theoretical Administration, Inhalation Viral Load Prospective Studies Follow-Up Studies Tumor Burden Immunotherapy

Phenomena and Processes24

Drug Synergism Drug Interactions Dose-Response Relationship, Drug Drug Resistance Drug Antagonism Apoptosis Inhibitory Concentration 50 Drug Resistance, Neoplasm Time Factors Cell Survival Drug Resistance, Multiple Cell Proliferation Drug Resistance, Viral Drug Resistance, Microbial Signal Transduction Cell Cycle Area Under Curve Algorithms Blood Pressure Cell Death Mutation Viral Load Cell Division Genotype

Disciplines and Occupations5

Drug Design Drug Discovery Pharmacology Systems Biology Computational Biology

Technology, Industry, Agriculture3

Cellophane Polyethylene Glycols Nanoconjugates

Information Science2

Algorithms Survival Rate

Health Care15

Treatment Outcome Clinical Trials as Topic Treatment Failure Clinical Trials, Phase I as Topic Survival Analysis Double-Blind Method Area Under Curve Models, Statistical Random Allocation Disease-Free Survival Randomized Controlled Trials as Topic Retrospective Studies Survival Rate Prospective Studies Follow-Up Studies

Geographicals3

Tanzania Cambodia Senegal

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Drug Combinations Drug Therapy, Combination Drug Synergism Artemisinins Antimalarials Drug Interactions Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Fluorenes Antineoplastic Agents Amodiaquine Cell Line, Tumor Dose-Response Relationship, Drug Mefloquine Pyrimethamine Drug Resistance Antiviral Agents Sulfadoxine Proguanil Ribavirin Ethanolamines Malaria, Falciparum Sesquiterpenes Xenograft Model Antitumor Assays Drug Administration Schedule Methenamine Chloroquine Drug Therapy Dapsone Drug Screening Assays, Antitumor Pyrazines Plasmodium falciparum Interferon-alpha Antihypertensive Agents Combined Modality Therapy Malaria Deoxycytidine Atovaquone Drug Antagonism Cisplatin Boronic Acids Drug Evaluation, Preclinical Apoptosis Fluorouracil Antifungal Agents Inhibitory Concentration 50 Drug Resistance, Neoplasm Anti-Bacterial Agents Microbial Sensitivity Tests Quinolines Time Factors Methylthioinosine Cyclopentolate Rifampin Clinical Trials as Topic Anti-HIV Agents Molecular Targeted Therapy Mice, Nude Doxorubicin Methotrexate Pyrimidines Tropicamide Amphotericin B Cellophane Paclitaxel Floxuridine Cell Survival Niacinamide Parasitic Sensitivity Tests Piperazines Echinocandins Phenylurea Compounds Sulfamethoxazole Hepatitis C, Chronic Antimetabolites, Antineoplastic Neoplasms Benzenesulfonates Taxoids Drug Resistance, Multiple Mice, SCID Amikacin Reverse Transcriptase Inhibitors Naphthoquinones Triazoles Cell Proliferation Pharmaceutical Preparations Parasitemia Administration, Oral Adenine Polyethylene Glycols Quinazolines Disease Models, Animal Drug-Related Side Effects and Adverse Reactions Sirolimus Antiprotozoal Agents Antibodies, Monoclonal Nanoconjugates Cyclophosphamide Angiotensin-Converting Enzyme Inhibitors Sulfonamides

No FAQ available that match "drug combination therapies"